Post Trial Access

Early Access Care is the solution to pharmaceutical company compliance with the new legislation as it pertains to Expanded Access.

Post-trial access may be managed via open-label roll-over study design, but there may be other alternatives that are appropriate for your development compound.

Our expertise is to develop and manage Post-Trial Access programs. Let us find the solution that offers you optimal flexibility, efficiency and value.